News

The targeted patient population included those with sickle cell disease or beta thalassemia who were considered at high risk for complications, or otherwise ineligible for standard myeloablative hematopoietic stem cell transplant.

Complete healing occurred after 4 weeks in 6 of the 10 RGN-259-treated subjects and in 1 of the 8 placebo-treated subjects.

Recent trial data showed positive results for B-VEC topical gene therapy treatment for dystrophic epidermolysis bullosa patients.

The average hepatitis C virus incidence was 52% lower during the broad-DAA access period.

A patient in their mid-50s with a history of diabetes who had already been on antibiotics for 4 days for cellulitis diagnosed in your emergency department, but had not improved, and then, yesterday, noticed an ankle wound. What additional testing should be considered for this patient?

Previous trials using acupuncture in patients with irritable bowel syndrome have suffered from problems of high placebo response rates.

This cardiology case report from Brady Pregerson, MD, features a patient in their early 70s presenting to the hospital with reports of shortness of breath, palpitations, and chest pain. Can you determine the correct diagnosis?

The results show similar rates o colonized C difficile among pediatric patients and adult patients with cystic fibrosis.

To celebrate the end of 2022 and the advances witnessed in the past year, our editorial team has created a list of the top 8 most popular pieces of content related to endocrinology from 2022.

A new cross-sectional analysis suggest there are few options available for patients with schizophrenia or a serious mood disorder.

Why has this season brought an unprecedented number of severe RSV infections, and why is vaccine development taking so long?

The approval for the non-surgical alternative was supported by phase 3 data showing ≥95% incidence eschar removal compared to a gel vehicle.

New longitudinal data support bolstered use of booster doses among health care workers in US nursing homes.

"The challenge right now is that we have no therapies in the emergency department to treat acute pain, outside of pain medications and IV opioids," Dr. Claudia Morris says in an interview.

The motive of the study wasn't to implement hematopoietic stem cell transplantation (HSCT) programs worldwide, but as a contribution to comprehensive cancer control efforts.

According to Dr. Corinna Schultz, a key part of the conversation of sickle cell trait (SCT) is centered around reproductive choices for the patient in the future.

Allergic contact dermatitis burden many people, but it is important for patients to know why and how they may limit their risk.

With less than a week to go until the close of 2022, our editorial team is celebrating the final week of the year by recapping some of our most popular stories and content from the past year. Here, we are highlighting our most popular episodes of the Don’t Miss a Beat Podcast from 2022.

An interview segment with Peter Young featuring a description of the response to the research into personal care product allergens.

A segment of an interview with Peter Young in which he describes his original interest in the subject of skincare product allergens.

Study data show the five-year incidence of fibrosis, atrophy, and MH were 34%, 26%, and 8%, respectively.

To commemorate the inaugural year and the success of Diabetes Dialogue in 2022, our editorial team has compiled a list of the 5 most popular episodes from the past year. Further in this article, we offer readers a look into each of our hosts top picks for episodes during 2022.

Cross-sectional data showed that rEZR reduced with increasing age, while longitudinal data indicate rEZR declined at a rate of ‒2.1 AU per year.

A look at the defining moments of the past year and what is expected to come in 2023.

This novel concept can benefit patients and clinicians alike by appropriately applying new technologies to identify bacteria more efficiently and decrease the time to optimal therapy.

RBX2660 is the first ever live microbiota therapeutic approved by the FDA.

Pregnant individuals with opioid use disorder are commonly treated with methadone.

A maternal-fetal medicine physician discusses plans for improvements in 2023.